Pancreatic cancer treatment with targeted therapies: are we there yet

Pancreatic cancer treatment with targeted therapies: are we there yet

Objective: Pancreatic cancer (PaCa) is a disease that is extremely difficult to treat and is associated with a high fatality rate. The majority of patients present to hospitals with metastatic or end-stage cancer, making the ultimate cure impossible. End-stage PaCa has no specific treatment, though...

Full description

Bibliographic Details
Main Authors:	Nwaefulu, O. Ngozi, Sagineedu, S. Rao, Islam, M. Kaisarul, Stanslas, J.
Format:	Article
Published:	Verduci International 2022

Similar Items

Pharmacological modulation of apoptosis and autophagy in pancreatic cancer treatment
by: Stanslas, Johnson, et al.
Published: (2022)

The impact of cycleanine in cancer research: a computational study
by: Nwaefulu, Ogochukwu Ngozi, et al.
Published: (2022)

Peptide-based and small molecule PD-1 and PD-L1 pharmacological modulators in the treatment of cancer
by: Islam, Mohammad Kaisarul, et al.
Published: (2021)

Immunotherapy updates in pancreatic cancer: are we there yet?
by: Krishna Soujanya Gunturu, et al.
Published: (2013-01-01)

Targeted Molecular Therapies in the Treatment of Esophageal Adenocarcinoma, Are We There Yet?
by: Shayan Khalafi, et al.
Published: (2020-10-01)

Modulation of macrophage polarity for treatment of acute pancreatitis: Are we there yet?
by: Preeti Sahay, et al.
Published: (2020-10-01)

Antioxidants for the Treatment of Breast Cancer: Are We There Yet?
by: Carmen Griñan-Lison, et al.
Published: (2021-01-01)

Ethnobotanical study of anticancer plants used in Ugbine, Nigeria and bioactivity-guided isolation of cytotoxic agents from Synclisia scabrida (Miers) ex oliv
by: Ngozi, Nwaefulu Ogochukwu
Published: (2022)

The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
by: Estefanía Moreno, et al.
Published: (2019-04-01)

We are not there yet
by: Margaret I. Fitch
Published: (2022-07-01)

Are we there yet?
by: Lajos Balogh
Published: (2023-03-01)

Are we there yet?
by: Nicole Swann
Published: (2019-06-01)

Are We There Yet
by: Ray T. Clifford
Published: (2007-01-01)

Cell-Based Therapies for Stroke: Are We There Yet?
by: Mirja Krause, et al.
Published: (2019-06-01)

More than just a KRAS inhibitor: DCAI abrogates the self-renewal of pancreatic cancer stem cells in vitro
by: Yuan, Han Teh, et al.
Published: (2023)

Adaptive therapy to circumvent drug resistance to tyrosine kinase inhibitors in cancer: is it clinically relevant?
by: Hamdi, Amir Imran Faisal, et al.
Published: (2022)

International Accreditation: Are We There Yet?
by: O. Michael Steve
Published: (2015-03-01)

Multiracialism : are we there yet?
by: Chia, Nicole Hui Ming, et al.
Published: (2016)

Editorial: Are we there yet?
by: Paulo E.C. Dantas
Published: (2015-01-01)

Why Are We Not There Yet?
by: Nanette K. Wenger, MD
Published: (2021-04-01)

Are We Growing Yet?
by: David A. Somers
Published: (2008-11-01)

Stem-cell therapy for hearing loss: are we there yet?
by: Luiz Gustavo Dufner-Almeida, et al.
Published: (2019-07-01)

Cancer vaccines<subtitle>Are we there yet?</subtitle>
by: Michael G. Hanna, Jr.
Published: (2012-08-01)

Endoscopic treatments of obesity and metabolic disease: are we there yet?
by: Barham K. Abu-Dayyeh, et al.

Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?
by: Si-Min Qi, et al.
Published: (2020-04-01)

The Challenges of Diagnosis and Treatment of Arrhythmogenic Cardiomyopathy: Are We there yet?
by: Alberto Spadotto, et al.
Published: (2022-08-01)

Safe Nanoparticles: Are We There Yet?
by: Wided Najahi-Missaoui, et al.
Published: (2020-12-01)

Are We Homo sapiens Yet?
by: Jarzombek, Mark
Published: (2019)

The Internet of Things: Are we there yet?
by: Jesus Alonso-Zarate
Published: (2016-12-01)

Precision Oncology: Are We There Yet?
Published: (2017-04-01)

MINOCA Today – Are We There Yet?
by: Mester András
Published: (2019-09-01)

Peak MSC—Are We There Yet?
by: Timothy R. Olsen, et al.
Published: (2018-06-01)

Robotics and ophthalmology: Are we there yet?
by: Suresh K Pandey, et al.
Published: (2019-01-01)

Regenerative medicine: are we there yet?
by: Stephen Badylak, et al.
Published: (2017-01-01)

Quantification of dementia: Are we there yet?
by: Avinash De Sousa
Published: (2018-01-01)

From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?
by: Pennuto, M, et al.
Published: (2017)

Andrographolide as a template in the synthesis of new anticancer agents with potentially novel molecular targets
by: Stanslas, Johnson, et al.
Published: (2010)

Hyperbaric oxygen therapy for the treatment of hypoxic/ischemic injury upon perinatal asphyxia—are we there yet?
by: Damian Mielecki, et al.
Published: (2024-04-01)

Acute Stroke Biomarkers: Are We There Yet?
by: Marie Dagonnier, et al.
Published: (2021-02-01)

Pharmacogenetics: reality or fiction? Or are we there yet?
by: Iscia Lopes-Cendes, et al.
Published: (2011-04-01)